ASX Share rice
Wed 05 Aug 2020 - 12:46:pm (Sydney)

LGP Share Price

LITTLE GREEN PHARMA LTDLGPPharmaceuticals, Biotechnology & Life Sciences

LGP Company Information

Name:

Little Green Pharma Ltd

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

Address:

PO Box 690 West Perth WA Australia 6872

Phone:

61 8 6280 0050

MD & Director:

Ms. Fleta Jennifer Solomon

Exec. Director:

Mr. Angus McDougall Caithness

Chief Financial Officer:

Mr. Bhavesh Morar

Chief Operating Officer:

Mr. Paul Long

Gen. Counsel & Company Sec.:

Mr. Alistair Warren B.A., L.L.B.

Company Overview:

Little Green Pharma Ltd engages in the research and development, cultivation, production, manufacturing, and distribution of medicinal cannabis products in Australia and internationally. It offers a range of medical cannabis preparations in oil formulation under the LGP Natural and LGP Advanced names. The company was founded in 2016 and is headquartered in West Perth, Australia.

LGP Share Price Information

Shares Issued:

133.50M

Market Capitalisation:

$44.06M

Revenue (TTM):

$0.94M

Revenue Per Share (TTM):

$0.01

Operating Margin (TTM):

$-7.09

Return On Assets (TTM):

$-1.08

Return On Equity (TTM):

$-4.69

Quarterly Revenue Growth (YOY):

25.605

Gross Profit(TTM):

$100.73K

Diluted Earnings Per Share (TTM):

$-0.123

LGP CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$1.50M

Change To Liabilities:

$1.26M

Total Cashflow From Investing Activities:

$1.03M

Net Borrowings:

$1.32M

Net Income:

$-5,518,129

Total Cash From Operating Activities:

$-3,321,403

Depreciation:

$84.40K

Change To Inventory:

$-351,134

Change To Account Receivables:

$-88,280

Capital Expenditures:

$374.61K

LGP Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-5,518,129

Net Income:

$-5,518,129

Gross Profit:

$100.73K

Operating Income:

$-5,170,872

Interest Expense:

$-4,681

Total Revenue:

$248.50K

Total Operating Expenses:

$5.42M

Cost Of Revenue:

$147.78K

LGP Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$158.06K

Total Liabilities:

$3.24M

Total Stockholder Equity:

$-1,288,068

Total Assets:

$1.96M

Common Stock:

$7.32M

Retained Earnings:

$-9,493,093

Other Assets:

$70.70K

Cash:

$510.29K

Total Current Liabilities:

$1.91M

Property - Plant & Equipment:

$609.62K

Net Tangible Assets:

$-1,446,132

Total Current Assets:

$1.12M

Long-Term Debt:

$1.33M

Net Receivables:

$88.28K

Inventory:

$513.74K

Accounts Payable:

$659.46K

LGP Share Price History

LGP News

20 Jul, 2020
Highlights: LGP granted ODC Medical Cannabis Cultivation and Production Permit for its expanded cultivation and manufacturing facility in Australia.Expanded Cultivation and.
28 May, 2020
April 2020 - a record sales month with 1,850+ units sold, a 17% increase on March 2020 (previous record sales month)380 new patients prescribed LGP products in April (for a.
11 May, 2020
LGP granted Manufacture Permit by the Office of Drug ControlLGP plans to commence in-house extraction operations, reducing manufacturing costs and improving manufacturing.
15 Apr, 2020
MONTRÉAL, April 15, 2020 (GLOBE NEWSWIRE) -- Elixxer Ltd. (ELXR.V)  (ELIXF) (FRA 2LQA) (“ELIXXER” or (the “Company”) is pleased to update that its pharmaceutical medical cannabis partner, Little Green Pharma (ASX:LGP) of Australia, has successfully exported their first shipment of medicinal cannabis products for patients into the UK. The products are to be distributed in the UK by Astral Health, a UK-based specialist importer and distributor of medicinal cannabis products and subsidiary of the LYPHE Group.